The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index.
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial
Open accessAbstract
Importance: Opportunistic screening for atrial fibrillation (AF) is recommended, and improved methods of early identification could allow for the initiation of appropriate therapies to prevent the adverse health outcomes associated with AF. Objective: To determine the effect of a self-applied wearable electrocardiogram (ECG) patch in detecting AF and the clinical consequences associated with such a detection strategy. Design, Setting, and Participants: A direct-to-participant randomized clinical trial and prospective matched observational cohort study were conducted among members of a large national health plan. Recruitment began November 17, 2015, and was completed on October 4, 2016, and 1-year claims-based follow-up concluded in January 2018. For the clinical trial, 2659 individuals were randomized to active home-based monitoring to start immediately or delayed by 4 months. For the observational study, 2 deidentified age-, sex- and CHA2DS2-VASc-matched controls were selected for each actively monitored individual. Interventions: The actively monitored cohort wore a self-applied continuous ECG monitoring patch at home during routine activities for up to 4 weeks, initiated either immediately after enrolling (n = 1364) or delayed for 4 months after enrollment (n = 1291). Main Outcomes and Measures: The primary end point was the incidence of a new diagnosis of AF at 4 months among those randomized to immediate monitoring vs delayed monitoring. A secondary end point was new AF diagnosis at 1 year in the combined actively monitored groups vs matched observational controls. Other outcomes included new prescriptions for anticoagulants and health care utilization (outpatient cardiology visits, primary care visits, or AF-related emergency department visits and hospitalizations) at 1 year. Results: The randomized groups included 2659 participants (mean [SD] age, 72.4 [7.3] years; 38.6% women), of whom 1738 (65.4%) completed active monitoring. The observational study comprised 5214 (mean [SD] age, 73.7 [7.0] years; 40.5% women; median CHA2DS2-VASc score, 3.0), including 1738 actively monitored individuals from the randomized trial and 3476 matched controls. In the randomized study, new AF was identified by 4 months in 3.9% (53/1366) of the immediate group vs 0.9% (12/1293) in the delayed group (absolute difference, 3.0% [95% CI, 1.8%-4.1%]). At 1 year, AF was newly diagnosed in 109 monitored (6.7 per 100 person-years) and 81 unmonitored (2.6 per 100 person-years; difference, 4.1 [95% CI, 3.9-4.2]) individuals. Active monitoring was associated with increased initiation of anticoagulants (5.7 vs 3.7 per 100 person-years; difference, 2.0 [95% CI, 1.9-2.2]), outpatient cardiology visits (33.5 vs 26.0 per 100 person-years; difference, 7.5 [95% CI, 7.2-7.9), and primary care visits (83.5 vs 82.6 per 100 person-years; difference, 0.9 [95% CI, 0.4-1.5]). There was no difference in AF-related emergency department visits and hospitalizations (1.3 vs 1.4 per 100 person-years; difference, 0.1 [95% CI, -0.1 to 0]). Conclusions and Relevance: Among individuals at high risk for AF, immediate monitoring with a home-based wearable ECG sensor patch, compared with delayed monitoring, resulted in a higher rate of AF diagnosis after 4 months. Monitored individuals, compared with nonmonitored controls, had higher rates of AF diagnosis, greater initiation of anticoagulants, but also increased health care resource utilization at 1 year. Trial Registration: ClinicalTrials.gov Identifier: NCT02506244.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One pioneering trial used a 'band-aid' patch sensor for detecting atrial fibrillation; the sensor was mailed to participants who were enrolled remotely, without the use of any clinical sites, and set the foundation for digitized clinical trials 37 .”
From Multimodal biomedical AI (2022) · cites this paper as [37]
Experimental — accuracy not yet measuredIn the citing paper
“AF screening via ECG patches in selected high-risk individuals is feasible and clinically valuable50”
From Smart wearable devices in cardiovascular care: Where we are and how to move forward (2021) · cites this paper as [50]
In the citing paper
“The study showed that ECG monitoring led to a higher rate of new AF diagnosis at 4 months and 1 year and was associated with the increased initiation of anticoagulation therapy and outpatient cardiology and primary care visits in patients without previously known AF50.”
From Smart wearable devices in cardiovascular care: Where we are and how to move forward (2021) · cites this paper as [50]
In the citing paper
“For example, iRhythm's single-use Zio patch monitors electrical pulses from the heart for 14 days, and is more effective than intermittent hospital check-ups at detecting abnormal rhythms 4 .”
From Skin sensors are the future of health care (2019) · cites this paper as [4]
In the citing paper
“For example, iRhythm's single-use Zio patch monitors electrical pulses from the heart for 14 days, and is more effective than intermittent hospital check-ups at detecting abnormal rhythms 4 .”
From Skin sensors are the future of health care (2019) · cites this paper as [4]
In the citing paper
“For instance, in the mSTOP trial, the information from the device was communicated to the patient and their primary physician, which led to higher rates of cardiology visits and follow-up investigations.”
From Unlocking Tomorrow’s Health Care: Expanding the Clinical Scope of Wearables by Applying Artificial Intelligence (2024) · cites this paper as [27]
In the citing paper
“This study showed that ECG monitoring analyzed by a deep learning model led to a higher rate of new AF diagnosis than standard methods, and was associated with increased initiation of anticoagulation therapy and cardiology referral.”
From Unlocking Tomorrow’s Health Care: Expanding the Clinical Scope of Wearables by Applying Artificial Intelligence (2024) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Antithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2304 · Cited by 933
Goldstein, L. B., Bushnell, C., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · Cited by 745
Dorian, P., Jung, W., Newman, D., Paquette, M., Wood, K., Ayers, G. M., Camm, J., Akhtar, M., & Luderitz, B. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00886-x · Cited by 627
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study
Svennberg, E., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman, V., & Rosenqvist, M. (2015) · Circulation · doi:10.1161/circulationaha.114.014343 · Cited by 605
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
Gelder, I. C. V., Healey, J. S., Crijns, H. J. G. M., Wang, J., Hohnloser, S. H., Gold, M. R., Capucci, A., Lau, C., Morillo, C. A., Hobbelt, A. H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx042 · Cited by 604
Halcox, J. P. J., Wareham, K., Cardew, A., Gilmore, M., Barry, J. P., Phillips, C., & Gravenor, M. B. (2017) · Circulation · doi:10.1161/circulationaha.117.030583 · Cited by 580
Barrett, P. M., Komatireddy, R., Haaser, S., Topol, S., Sheard, J., Encinas, J., Fought, A. J., & Topol, E. J. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.10.003 · Cited by 498
Self-citationLowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0231 · Cited by 458
Chen, L. Y., Chung, M. K., Allen, L. A., Ezekowitz, M. D., Furie, K. L., McCabe, P. J., Noseworthy, P. A., Perez, M. V., & Turakhia, M. P. (2018) · Circulation · doi:10.1161/cir.0000000000000568 · Cited by 454
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371
Jensen, P. N., Johnson, K. E., Floyd, J. S., Heckbert, S. R., Carnahan, R. M., & Dublin, S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2317 · Cited by 336
Liao, J., Khalid, Z., Scallan, C., Morillo, C., & O’Donnell, M. (2007) · Stroke · doi:10.1161/strokeaha.106.478685 · Cited by 331
High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke
Friberg, L., Rosenqvist, M., Lindgren, A. G., Terént, A., Norrving, B. G., & Asplund, K. (2014) · Stroke · doi:10.1161/strokeaha.114.006070 · Cited by 319
Vanassche, T., Lauw, M. N., Eikelboom, J. W., Healey, J. S., Hart, R. G., Alings, M., Avezum, A., Diaz, R., Hohnloser, S. H., Lewis, B. S., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu307 · Cited by 313
Mahajan, R., Perera, T., Elliott, A. D., Twomey, D. J., Kumar, S. K., Munwar, D. A., Khokhar, K. B., Thiyagarajah, A., Middeldorp, M. E., Nalliah, C. J., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx731 · Cited by 284
Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation
Weng, L.-C. C., Preis, S. R., Hulme, O. L., Larson, M. G., Choi, S. H., Wang, B., Trinquart, L., McManus, D. D., Stærk, L., Lin, H., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031431 · Cited by 276
Reiffel, J. A., Verma, A., Kowey, P. R., Halperin, J. L., Gersh, B. J., Wachter, R., Pouliot, E., Ziegler, P., & for the REVEAL AF Investigators (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3180 · Cited by 267
Subclinical Atrial Fibrillation in Older Patients
Healey, J. S., Alings, M., Ha, A. C. T., Leong‐Sit, P., Birnie, D. H., de Graaf, J. J., Freericks, M. P., Verma, A., Wang, J., Leong, D. P., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028845 · Cited by 249
Hannon, N., Sheehan, O. C., Kelly, L., Marnane, M., Merwick, Á., Moore, A. R., Kyne, L., Duggan, J., Moroney, J. T., McCormack, P. M. E., et al. (2009) · Cerebrovascular Diseases · doi:10.1159/000255973 · Cited by 231
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation
Link, M. S., Giugliano, R. P., Ruff, C. T., Scirica, B. M., Huikuri, H., Oto, A., Crompton, A. E., Murphy, S. A., Lanz, H., Mercuri, M. F., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004267 · Cited by 181
Newly Diagnosed Atrial Fibrillation and Acute Stroke
Lin, H., Wolf, P. A., Benjamin, E. J., Belanger, A. J., & D’Agostino, R. B. (1995) · Stroke · doi:10.1161/01.str.26.9.1527 · Cited by 171
Ziegler, P., Glotzer, T. V., Daoud, E. G., Singer, D. E., Ezekowitz, M. D., HOYT, R. H., Koehler, J. L., Coles, J. A., & Wyse, D. G. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.06.034 · Cited by 164
Stroke and Thromboembolism in Atrial Fibrillation
Pisters, R., Lane, D. A., Marín, F. R., Camm, A. J., & Lip, G. Y. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1036 · Cited by 162
Quality of life in patients with silent atrial fibrillation
Savelieva, I., PAQUETTE, M., Dorian, P., LÜDERITZ, B., & CAMM, A. J. (2001) · Heart · doi:10.1136/heart.85.2.216 · Cited by 112
Friberg, L., Engdahl, J., Frykman, V., Svennberg, E., Levin, L.-Å., & Rosenqvist, M. (2013) · EP Europace · doi:10.1093/europace/eus217 · Cited by 100
Nasir, J. M., Pomeroy, W. C., Marler, A. T., Hann, M. C., Baykaner, T., Jones, R., Stoll, R., Hursey, K., Meadows, A., Walker, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.04.026 · Cited by 92
Lowres, N., Krass, I., Neubeck, L., Redfern, J., McLachlan, A. J., Bennett, A. A., & Freedman, B. (2015) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0169-1 · Cited by 84
Prevalence of unknown atrial fibrillation in patients with risk factors
Samol, A., Masin, M., Gellner, R., Otte, B., Pavenstädt, H.-J., Ringelstein, E. B., Reinecke, H., Waltenberger, J. L., & Kirchhof, P. F. (2012) · EP Europace · doi:10.1093/europace/eus366 · Cited by 72
Rizos, T., Wagner, A., Jenetzky, E., Ringleb, P. A., Becker, R., Hacke, W., & Veltkamp, R. C. (2011) · Cerebrovascular Diseases · doi:10.1159/000330348 · Cited by 69
Proietti, M., Mairesse, G. H., Goethals, P., Scavée, C., Vijgen, J. M., Blankoff, I., Vandekerckhove, Y. R., & Lip, G. Y. H. (2016) · EP Europace · doi:10.1093/europace/euw069 · Cited by 68
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub2 · Cited by 61
Steinhubl, S. R., Mehta, R. R., Ebner, G. S., Ballesteros, M. M., Waalen, J., Steinberg, G., Crocker, P. V., Felicione, E., Carter, C. T., Edmonds, S., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.02.011 · Cited by 59
Self-citationCaldwell, J. C., Contractor, H., Petkar, S., Ali, R., Clarke, B., Garratt, C. J., Neyses, L., & Mamas, M. A. (2009) · EP Europace · doi:10.1093/europace/eup201 · Cited by 54
Atrial fibrillation detection using a smart phone
Lee, J., Reyes, B. A., McManus, D. D., Mathias, O., & Chon, K. H. (2012) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2012.6346146 · Cited by 53
Randomized, Controlled Trials in Health Insurance Systems
Choudhry, N. K. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510058 · Cited by 48
Validation of a genetic risk score for atrial fibrillation: A prospective multicenter cohort study
Muse, E. D., Wineinger, N. E., Spencer, E. G., Peters, M., Henderson, R., Zhang, Y., Barrett, P. M., Rivera, S. P., Wohlgemuth, J. G., Devlin, J. J., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002525 · Cited by 32
Self-citationSteinhubl, S. R., McGovern, P. E., Dylan, J., & Topol, E. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32741-1 · Cited by 29
Self-citation‘What else can I do?’: Insights from atrial fibrillation patient communication online
Redman, K. N., Thorne, S. E., Lauck, S., & Taverner, T. (2016) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515116678103 · Cited by 18
Subclinical atrial fibrillation in need of more assertive evidence
Rahimi, K. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx122 · Cited by 17
USQA Health Profile Database as a tool for health plan quality improvement.
Hanchak, N. A., Jf, M., Hirsch, A., Pd, M., & Schlackman, N. (1996) · PubMed · Cited by 14
Morillas, P., Pallarés‐Carratalá, V., Llisterri, J. L., Sanchís, C., Sánchez, T., Fácila, L., Pérez‐Alonso, M., Castillo, J., Redón, J., & Bertoméu, V. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70188-2 · Cited by 13
Flagged first, then by citations
2 of the 51 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Proietti, 2016, A population screening programme for atrial fibrillation., Europace, 18, 1779
Cited by
Sorted by citations
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Gelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,594
“102 There have been several studies investigating the cost-effectiveness of screening for AF.”
BackgroundLarge-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., Balasubramanian, V., Russo, A. M., Rajmane, A., Cheung, L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901183 · Cited by 1,917
Acosta, J. N., Falcone, G. J., Rajpurkar, P., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-022-01981-2 · Cited by 1,365
“One pioneering trial used a ‘band-aid’ patch sensor for detecting atrial fibrillation; the sensor was mailed to participants who were enrolled remotely, without the use of any clinical sites, and set the foundation for digitized clinical trials 37 .”
MethodSelf-citationSmart wearable devices in cardiovascular care: Where we are and how to move forward
Bayoumy, K., Gaber, M., Elshafeey, A., Mhaimeed, O., Dineen, E. H., Marvel, F. A., Martin, S. S., Muse, E. D., Turakhia, M. P., Tarakji, K. G., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00522-7 · Cited by 829
Metadata
- Authors
- Steinhubl, S. R., Waalen, J., Edwards, A. M., Ariniello, L. M., Mehta, R. R., Ebner, G. S., Carter, C., Baca-Motes, K., Felicione, E., Sarich, T., & Topol, E. J.
- Affiliations
- Scripps Translational Science Institute, La Jolla, California
- Healthagen Outcomes, Chicago, Illinois
- Janssen Scientific Affairs (United States) (US)
- Corresponding author
- Steinhubl, Steven R.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-07-10
- Volume
- 320
- Issue
- 2
- Pages
- 146
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6583518
- OpenAlex
- W2869528658
- Cited by
- 539
- References
- 51
- Citations by year
- 2026: 65 · 2025: 70 · 2024: 58 · 2023: 56 · 2022: 72 · 2021: 79 · 2020: 68 · 2019: 58 · 2018: 13
- FWCI
- 41.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR001114)
- National Center for Advancing Translational Sciences
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
- Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
- Keywords
- atrial fibrillation, opportunistic screening, undiagnosed atrial fibrillation, anticoagulant prescription, health care utilization, CHA2DS2-VASc score, stroke prevention, older adults, health insurance beneficiaries, emergency department visits, hospitalization, primary care visits, cost-effectiveness
- MeSH terms
- Wearable Electronic Devices, Aged, Anticoagulants, Atrial Fibrillation, Female, Health Resources, Humans, Male, Mass Screening, Middle Aged, Risk Factors, Cohort Studies, Electrocardiography, Ambulatory, Comorbidity, Incidence, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
